Orthometrix, Inc.
OMRX · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $130 | $226 | $364 | $737 |
| % Growth | -42.5% | -37.8% | -50.6% | – |
| Cost of Goods Sold | $118 | $158 | $193 | $397 |
| Gross Profit | $13 | $68 | $171 | $339 |
| % Margin | 9.7% | 30.1% | 47% | 46.1% |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $148 | $152 | $197 | $0 |
| SG&A Expenses | $253 | $247 | $322 | $319 |
| Sales & Mktg Exp. | $105 | $95 | $125 | $0 |
| Other Operating Expenses | -$480 | -$359 | -$303 | $39 |
| Operating Expenses | -$228 | -$112 | $19 | $359 |
| Operating Income | $240 | $180 | $151 | -$20 |
| % Margin | 184.6% | 79.4% | 41.6% | -2.7% |
| Other Income/Exp. Net | -$240 | -$180 | -$151 | $20 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$310 | -$265 | -$241 | -$143 |
| % Margin | -238% | -117.3% | -66.3% | -19.4% |
| EPS | -0.01 | -0.01 | -0.01 | -0.003 |
| % Growth | 0% | 0% | -222.6% | – |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.003 |
| Weighted Avg Shares Out | 49,639 | 47,316 | 45,987 | 45,610 |
| Weighted Avg Shares Out Dil | 49,639 | 47,316 | 45,987 | 45,610 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $70 | $86 | $99 | $0 |
| Depreciation & Amortization | $51 | $4 | $4 | $4 |
| EBITDA | -$189 | -$175 | -$147 | $24 |
| % Margin | -145.6% | -77.6% | -40.5% | 3.3% |